These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 4895062)
1. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate). Albert M; Stansell MJ Metabolism; 1969 Aug; 18(8):635-45. PubMed ID: 4895062 [No Abstract] [Full Text] [Related]
2. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate]. Noleto PA; de Bulhões F; Tuma M Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870 [No Abstract] [Full Text] [Related]
3. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate). Bergqvist N Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978 [No Abstract] [Full Text] [Related]
4. Peripheral vascular disease improved by clofibrate. Exp Med Surg; 1968; 26(4):277-9. PubMed ID: 5736504 [No Abstract] [Full Text] [Related]
5. The Coronary Drug Project. Initial findings leading to modifications of its research protocol. JAMA; 1970 Nov; 214(7):1303-13. PubMed ID: 4320008 [No Abstract] [Full Text] [Related]
6. [Treatment of arteriosclerosis by Atromid]. Ayad H Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185 [No Abstract] [Full Text] [Related]
7. [Clinical studies with a new anticoronaritis preparation]. Amadini S; Bagnoli L Minerva Cardioangiol; 1969 Aug; 17(8):532-48. PubMed ID: 5402252 [No Abstract] [Full Text] [Related]
8. [Currently used therapeutic agents for arteriosclerosis--with special reference to a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4915308 [No Abstract] [Full Text] [Related]
9. [Currently used therapeutic agents for arteriosclerosis--with special reference ro a protein anabolic hormone, clofibrate (C.P.I.B.)]. Yasugi T; Sasa E Nihon Rinsho; 1970 May; 28(5):1470-4. PubMed ID: 4916330 [No Abstract] [Full Text] [Related]
10. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens. Watermeyer GS; Mann JI; Truswell AS; Levy I S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562 [TBL] [Abstract][Full Text] [Related]
16. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia. Howard AN; Hyams DE Br Med J; 1971 Jul; 3(5765):25-7. PubMed ID: 4933388 [TBL] [Abstract][Full Text] [Related]
18. Exercise tolerance in patients with angina pectoris: daily variation and effect of pentaerythritol tetranitrate. Dagenais GR; Mason RE; Friesinger GC; Wender C; Ross RS Johns Hopkins Med J; 1969 Dec; 125(6):301-11. PubMed ID: 4905736 [No Abstract] [Full Text] [Related]
19. A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy. Harrold BP; Marmion VJ; Gough KR Diabetes; 1969 May; 18(5):285-91. PubMed ID: 4894161 [No Abstract] [Full Text] [Related]
20. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate. Nordoy A; Rodset JM Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488 [No Abstract] [Full Text] [Related] [Next] [New Search]